1. Home
  2. CERS vs BSVN Comparison

CERS vs BSVN Comparison

Compare CERS & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • BSVN
  • Stock Information
  • Founded
  • CERS 1991
  • BSVN 2004
  • Country
  • CERS United States
  • BSVN United States
  • Employees
  • CERS N/A
  • BSVN N/A
  • Industry
  • CERS EDP Services
  • BSVN Major Banks
  • Sector
  • CERS Technology
  • BSVN Finance
  • Exchange
  • CERS Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • CERS 347.3M
  • BSVN 335.6M
  • IPO Year
  • CERS 1997
  • BSVN 2018
  • Fundamental
  • Price
  • CERS $1.27
  • BSVN $38.62
  • Analyst Decision
  • CERS Strong Buy
  • BSVN Buy
  • Analyst Count
  • CERS 2
  • BSVN 2
  • Target Price
  • CERS $3.50
  • BSVN $51.00
  • AVG Volume (30 Days)
  • CERS 1.2M
  • BSVN 21.2K
  • Earning Date
  • CERS 05-01-2025
  • BSVN 07-10-2025
  • Dividend Yield
  • CERS N/A
  • BSVN 2.46%
  • EPS Growth
  • CERS N/A
  • BSVN 46.15
  • EPS
  • CERS N/A
  • BSVN 4.71
  • Revenue
  • CERS $185,144,000.00
  • BSVN $96,026,000.00
  • Revenue This Year
  • CERS $22.37
  • BSVN N/A
  • Revenue Next Year
  • CERS $8.46
  • BSVN $3.53
  • P/E Ratio
  • CERS N/A
  • BSVN $8.20
  • Revenue Growth
  • CERS 13.06
  • BSVN 28.97
  • 52 Week Low
  • CERS $1.12
  • BSVN $27.84
  • 52 Week High
  • CERS $2.54
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • CERS 46.48
  • BSVN 55.00
  • Support Level
  • CERS $1.21
  • BSVN $37.62
  • Resistance Level
  • CERS $1.35
  • BSVN $39.41
  • Average True Range (ATR)
  • CERS 0.06
  • BSVN 1.16
  • MACD
  • CERS -0.00
  • BSVN 0.02
  • Stochastic Oscillator
  • CERS 38.89
  • BSVN 60.84

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: